Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

BACKGROUND. Three‐weekly high‐dose cisplatin (100 mg/m(2)) is considered the standard systemic regimen given concurrently with postoperative or definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LA‐SCCHN). However, due to unsatisfactory patient tolerance, vario...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Castro, Ana, Licitra, Lisa, Adelstein, David, Vermorken, Jan B.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2017
Teme:
Head and Neck Cancers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599190/
https://ncbi.nlm.nih.gov/pubmed/28533474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0015
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki